Neurocrine Biosciences, Inc. (NBIX)
NASDAQ·Healthcare·Biotechnology
$157.15
+0.37%
Mkt Cap $15.65B
Analyst Ratings
Buy
31
Hold
4
Sell
0
Price Target (69 analysts)
$188.62
Range $140.00 – $230.00
Implied Upside
+20.0%
Consensus $188.62 vs current $157.15